Skip to content

use of fatty acid capsule as a dietary supplement in management of patients with chronic periodontal disease.

Clinico- immunological evaluation of Use of Omega 3 Fatty Acids asNutraceutical Approach in Management of Patients With Chronic Periodontitis – A Randomized clinical Trial.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036554
Enrollment
30
Registered
2021-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: Use of Omega 3 Fatty acid capsule: one side only SRP. Other side as an adjunct, use 500 mg capsule Omega 3 fatty acid 2 times for 3 months Control Intervention1: Omega 3 Fatty Acids: As

Sponsors

DGAFMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with severe form of chronic generalized periodontitis with more than =30% of the sites showing =5.0 mm of clinical attachment loss 2. No systemic diseases that could influence the outcome of the therapy 3.Non-smokers 4.Compliance with the maintenance program 5.No use of antibiotics or anti ?inflammatory drugs in the past 6 months

Exclusion criteria

Exclusion criteria: i.Patients with previous systemic conditions and pregnant females ii.Patients allergic to local anesthetics, chlorhexidine, antibiotics and analgesics iii.Previous history of intolerance to polyunsaturated fatty acids iv.Patients who had a habit of smoking and tobacco chewing. v.Patients who underwent periodontal surgery 1 year back vi.Patients requiring any emergency dental treatment

Design outcomes

Primary

MeasureTime frame
a.Levels of interleukin-1 beta (IL-1ß) by ELISA b.Clinical Attachment Level (CAL) Timepoint: 0,3,6 months

Secondary

MeasureTime frame
1.Probing Depth (PD) 2.Gingival bleeding Index (GBI) 3.Plaque Index (PI) Timepoint: 0,3,6 months

Countries

India

Contacts

Public ContactT PRASANTH

AFMC,PUNE

tprasanthavin@gmail.com8284851155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026